28.02.2013 Views

Handbook of Solvents - George Wypych - ChemTech - Ventech!

Handbook of Solvents - George Wypych - ChemTech - Ventech!

Handbook of Solvents - George Wypych - ChemTech - Ventech!

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

1394 David K. Bonauto, C. Andrew Brodkin, William O. Robertson<br />

supply or the portal triad, zone one, are more resistant to oxidative stress, while hepatocytes<br />

near the central vein, zone three or centrizonal region, are most susceptible to solvent induced<br />

injury.<br />

20.8.1.1 Factors Influencing Solvent Hepatotoxicity<br />

Bioavailability: The physical and chemical properties <strong>of</strong> a solvent and its toxicokinetics determine<br />

its availability to hepatic tissues. The primary route <strong>of</strong> absorption <strong>of</strong> most solvents<br />

which cause hepatotoxicity into human biological systems is via the lung. Therefore, the<br />

greater the volatility <strong>of</strong> the solvent, the greater its concentration in the air, and subsequently<br />

the larger the potential dose. 4 While accidental or intentional ingestion <strong>of</strong> solvents is reported<br />

in the medical literature, it is an uncommon route <strong>of</strong> exposure in the occupational setting.<br />

Dermal absorption should be considered a significant route <strong>of</strong> exposure for most<br />

solvent compounds based on their lipid solubility. The degree <strong>of</strong> exposure can <strong>of</strong>ten be<br />

modified by the use <strong>of</strong> personal protective equipment such as gloves or a respirator and engineered<br />

exposure controls such as building ventilation.<br />

The lipid solubility <strong>of</strong> solvents also favors their deposition <strong>of</strong> into lipid rich organ systems<br />

such as the liver. The toxicity <strong>of</strong> a particular solvent may be enhanced by its long residence<br />

time in the liver. 6<br />

Genetic and environmental factors: While some solvents are directly hepatotoxic, frequently<br />

biotransformation <strong>of</strong> solvents by hepatic mixed function oxygenases, such as the<br />

cytochrome p-450 system, result in toxic intermediates. 7 A variety <strong>of</strong> genetic and environmental<br />

factors inhibit or induce the activity <strong>of</strong> these hepatic enzyme systems, effecting the<br />

biotransformation and resulting toxicity. Genetic factors thought to determine the activity<br />

or even the presence <strong>of</strong> an enzyme within an organism center around human polymorphisms<br />

or variations in the genetic code. 7 As the activities <strong>of</strong> the liver enzymes are changed so will<br />

the rate <strong>of</strong> formation <strong>of</strong> the metabolite thus increasing or decreasing the toxicity <strong>of</strong> the foreign<br />

substance. 3 Environmental factors which determine the activity <strong>of</strong> liver enzyme systems<br />

include co-exposure to other drugs and toxins or characteristics <strong>of</strong> the individual<br />

particularly disease states which induce or inhibit the activity <strong>of</strong> liver biotransformation enzymes.<br />

1,3,7-9 Individual characteristics such as age, nutritional status, pregnancy or disease<br />

states such as diabetes or obesity may also change the activity <strong>of</strong> cytochrome p-450 enzymes.<br />

7,9 The assessment <strong>of</strong> an individual’s susceptibility to exposure should attempt to account<br />

for these variables in determining risk.<br />

20.8.1.2 Microscopic, Biochemical and Clinical Findings Associated with<br />

Liver Injury due to <strong>Solvents</strong><br />

Hepatotoxic manifestations associated with acute solvent exposure are dose dependent.<br />

Acute cytotoxic injury <strong>of</strong> a solvent directly or by its metabolites causes an alteration in the<br />

normal physiologic function leading to ballooning fatty change and ultimately cellular necrosis.<br />

If the dose is minimal and doesn’t exceed the ‘regenerative capacity’ <strong>of</strong> the liver, inflammatory<br />

changes generally resolve within two weeks to several months. Metabolic<br />

derangement results in the accumulation <strong>of</strong> fats in the liver, termed steatosis. 10 A less common<br />

form <strong>of</strong> acute cytotoxic injury is related to cholestatic injury with disruption <strong>of</strong> normal<br />

biliary flow. 11 Severe long term exposures can lead to fibrosis or scarring and cirrhosis<br />

which distort the hepatic architecture and lead to altered liver function.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!